BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Biotechnology and Pharmaceutical ChannelMedical Device and Diagnostics ChannelClinical Research Channel


NEWSLETTERS
FREENewsletters
Archive

NEWS
News bySubject
News byDisease
News byDate
PLoS
SearchNews

CAREER NETWORK
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

DIVERSITY

HOTBEDS
Regional News
BiotechBay™
BiotechBeach™
Genetown™
PharmCountry™
BioCapital™
BioMidwest™
BioNC™
BioForest™
SouthernPharm™
BioCanadaEast™
US Device™

INVESTOR
Market Summary
News
IPOs

PROFILES
CompanyProfiles

START UPS
Companies
Events

INTELLIGENCE
BioPharm Insight

INDUSTRY EVENTS
Biotech Events
Post an Event

RESOURCES
RealEstate
Business Opportunities
Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
My Watchlist
Indicators
Nymox Pharmaceutical Corp (NQ: NYMX)
5.150 USD  +0.010 (+0.19%)
Streaming Delayed Price  /  Updated: 11:07 AM EDT, May 21, 2013  /  Add to My Watchlist      
View: Quote News Research
Price and Volume
Detailed Quote
Chart for (: )
 
Intraday
1 Week
1 Month
3 Month
1 Year
  
Compare to:
Volume 25,333
Open 5.200
Bid (Size) 5.150 (600)
Ask (Size) 5.200 (100)
Prev. Close 5.140
Today's Range 4.990 - 5.260
52wk Range 4.200 - 8.528
Shares Outstanding 33,945,917
Dividend Yield N/A
Top News
More News
Nymox Pharmaceutical Corp (NYMX) Posts Q1 Loss of 3c/Share
May 15, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8340436 for the full story. Read More
from StreetInsider.com News Articles
Nymox Reports First Quarter 2013 Financial Results
May 15, 2013
from GlobeNewswire News Releases

More News
Read More
20.0% Return Seen to Date on SmarTrend Nymox Pharmaceutical Call (NYMX)
May 07, 2013
from Comtex SmarTrend® News Briefs
Nymox Reports on Symposium and Panel Discussion on NX-1207 at American Urological Association Annual Meeting
May 06, 2013
from GlobeNewswire News Releases
Nymox Announces Completion of Patient Enrollment in Final Pivotal U.S. Phase 3 BPH Study
May 03, 2013
from GlobeNewswire News Releases
Nymox NX-1207 Symposium May 5 in San Diego at Annual Meeting of American Urological Association at San Diego Convention Center
April 30, 2013
from GlobeNewswire News Releases
Nymox Pharma (NYMX) Commences NX-1207 Study on BPH
April 23, 2013
from StreetInsider.com News Articles
Nymox Announces First Patient Enrollment for NX02-0022 Reinjection Study of NX-1207 for BPH
April 23, 2013
from GlobeNewswire News Releases
New Study Supports Favorable Sexual Function Profile for Nymox's NX-1207 for Prostate Enlargement
April 16, 2013
from GlobeNewswire News Releases
Downtrend Call Working As Nymox Pharmaceutical Stock Falls 20.1% (NYMX)
April 12, 2013
from Comtex SmarTrend® News Briefs
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here
About BioSpace | Contact Us | Privacy Statement | Terms of Use
Post Your News | Post Event | Post Jobs | Post Company Profile | Advertising Opportunities

RSS FEED All News | Breaking News | Featured Stories

© 2007 BioSpace, Inc - an onTargetjobs company
Visit other onTargetjobs companies
Niche Job Boards | Biotechnology Jobs | Healthcare Jobs | Nursing Jobs | Accounting Jobs | Hospitality Jobs
Hospitality Jobs Canada | Hospitality Jobs UK